SYRE

Spyre Therapeutics Inc

Jun 17 • 04:00PM ET

87.49

+4.08 4.89 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN RYTM APGE KRYS KYMR NUVL AXSM MDGL VKTX NBIX

| Held by: VTI IWM XBI VXF IBB IWO SCHA VTWO IWN VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.36	Insider Own	10.85%	Shs Outstand	78.84M	Perf Week	16.53%
Market Cap	7.60B	Forward P/E	-	EPS next Y	-3.20	Insider Trans	-3.03%	Shs Float	77.42M	Perf Month	24.84%
Enterprise Value	7.01B	PEG	-	EPS next Q	-0.76	Inst Own	87.15%	Short Float	16.31%	Perf Quarter	103.18%
Income	-168.74M	P/S	-	EPS this Y	-52.10%	Inst Trans	1.15%	Short Ratio	10.83	Perf Half Y	162.42%
Sales	0.00M	P/B	13.39	EPS next Y	-6.28%	ROA	-25.30%	Short Interest	12.63M	Perf YTD	167.06%
Book/sh	6.53	P/C	10.25	EPS next 5Y	-23.44%	ROE	-29.26%	52W High	84.93 3.02%	Perf Year	476.35%
Cash/sh	8.54	P/FCF	-	EPS past 3/5Y	57.01% 44.61%	ROIC	-25.15%	52W Low	13.93 528.06%	Perf 3Y	2405.08%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.51% 5.95%	Perf 5Y	-46.41%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	22.31%	Oper. Margin	-	ATR (14)	4.52	Perf 10Y	-21.53%
Dividend Ex-Date	-	Quick Ratio	8.97	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	68.63	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	8.97	EPS Q/Q	-46.71%	SMA20	15.35%	Beta	3.04	Target Price	99.13
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	21.51%	Rel Volume	1.30	Prev Close	83.41
Employees	102	LT Debt/Eq	0.00	Earnings	May 05 BMO	SMA200	115.87%	Avg Volume	1.17M	Price	87.49
IPO	Apr 07, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-11.18% -	Trades		Volume	1,513,724	Change	4.89%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)